[Breaking] Prosecution Conducts Search and Seizure at ShillaJen Seoul Office and CEO Moon Eun-sang's Residence
Shinilajen, which received a recommendation to halt clinical trials of the virus-based immuno-oncology drug 'Pexavac,' held an emergency briefing on the afternoon of August 4 last year at the CCMM Building in Yeouido, Seoul, to provide supplementary explanations on the futility assessment results. Moon Eun-sang, CEO of Shinilajen, is bowing his head in greeting. [Image source=Yonhap News]
View original image[Asia Economy Reporter Yoo Byung-don] The prosecution has once again conducted a search and seizure on the bio company Sillajen, which is suspected of selling stocks in advance using insider information.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.